Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

Download PDF Copy

Sep 1 2009

NewsGuard 100/100 Score

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the UBS Global Life Sciences Conference in New York at 11:00 a.m. Eastern Time on Monday, September 21, 2009. Mr. Kazimi will provide an update on the Company and its Caldolor product, which Cumberland is preparing to launch following its recent approval by the Food and Drug Administration.

The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section on Cumberland Pharmaceuticals' website at www.cumberlandpharma.com. Shortly following the live webcast, a replay will be available and archived for 30 days.

Source: http://www.cumberlandpharma.com

Posted in: Pharmaceutical News

Tags: Acetaminophen, C-section, Food, Gastroenterology, Hospital, Pharmaceuticals

Comments (0)

Download PDF Copy

Suggested Reading

Keck Hospital of USC receives ninth "A" Hospital Safety Grade from The Leapfrog Group

Keck Hospital of USC receives ninth "A" Hospital Safety Grade from The Leapfrog Group

Children's Colorado earns prestigious cardiomyopathy recognition

Children's Colorado earns prestigious cardiomyopathy recognition

Study shows community health workers can improve asthma care for children

Study shows community health workers can improve asthma care for children

Air pollution increases emergency department visits

Air pollution increases emergency department visits

$Longer waits in emergency care impact outcomes for hip fracture patients, study shows$

Longer waits in emergency care impact outcomes for hip fracture patients, study shows

NCCN leaders collaborate to enhance cancer care in Vietnam

NCCN leaders collaborate to enhance cancer care in Vietnam

Innovative approach by Waymark enhances health outcomes for Medicaid patients

Innovative approach by Waymark enhances health outcomes for Medicaid patients

Researchers uncover key mechanisms of CRISPR gene editing

Researchers uncover key mechanisms of CRISPR gene editing

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Non-Hispanic Black children and low-income youth disadvantaged in concussion care